Studies back linagliptin's efficacy in glucose control

10/3/2012 | Healio

Four studies presented at the European Association for the Study of Diabetes meeting showed linagliptin alone or in combination with other diabetes drugs or basal insulin treatment significantly improved blood glucose levels without increasing the risk of hypoglycemia or weight gain in adults and elderly patients with type 2 diabetes. One study also showed linagliptin therapy reduced albuminuria in type 2 diabetes patients with early nephropathy.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA